Collaborative projects

Within the framework of a project funded by German Cancer Aid (Deutsche Krebshilfe) , the Universities of Bonn and Cologne, together with the MVZ Oncology Oskar-Helene-Heim in Berlin, are developing a new instrument to measure medication literacy of patients receiving oral anticancer drug therapy.

As part of a collaborative project funded by the German Federal Ministry of Health (BMG), the Universities of Bonn and Erlangen are establishing a Germany-wide safety network for oral anticancer therapy with 24 centres consisting of hospitals, oncology practices and community pharmacies. The aim is to strengthen interprofessional on-site competence in the care of patients with oral anticancer therapy and to improve medication safety.

The use case POLAR "POLypharmacy, Drug Interactions and Risks", funded by the German Federal Ministry of Education and Research (BMBF) as part of the Medical Informatics Initiative (MII), aims to contribute to the detection of health risks in patients with polypharmacy using methods and pfrom the Medical Informatics Initiative.

INTERPOLAR, as a follow-up project to POLAR, is an intervention study funded by the German Federal Ministry of Education and Research (BMBF). Within the framework of INTERPOLAR, we investigate whether a risk analysis based on electronic patient data can reliably identify medication-related problems and reduce them in everyday clinical practice. The overall aim is to use the limited time resources of physicians and clinical pharmacists more efficiently.

Together with other departments of Clinical Pharmacy and Clinical Pharmacology at German Universities, we aim to establish a nationwide infrastructure for Therapeutic Drug Monitoring (TDM) in patients with oral anticancer therapy. The non-interventional study ON-TARGET focuses on TDM of axitinib and cabozantinib in renal cell carcinoma patients and the feasibility of the VAMS® technology for sample collection.

As part of the WILMA project funded by the German Federal Ministry of Health (BMG), a postgraduate interprofessional Master's programme for Medication Safety has been established and evaluated.